+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Ovarian Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 118 Pages
  • Global
From
From
Gastrointestinal Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Bacteraemia - Pipeline Insight, 2024 - Product Thumbnail Image

Bacteraemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Gene Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gene Therapy Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Transforming growth factor beta inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming growth factor beta inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
From
From
From
From
From
From
Dermatology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Dermatology Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Digital Marketing Trends in Hepatocellular Carcinoma - Product Thumbnail Image

Digital Marketing Trends in Hepatocellular Carcinoma

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Anti-Allergy Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Allergy Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 86 Pages
  • Global
From
From
Loading Indicator